1. Home
  2. |Insights
  3. |EPA Administrator’s Resignation Letter Touts CAFO Rule Among Environmental Achievements

EPA Administrator’s Resignation Letter Touts CAFO Rule Among Environmental Achievements

Client Alert | less than 1 min read | 05.25.03

EPA Administrator Christie Whitman tendered her resignation to President Bush on May 20, citing her wish to return to her home and family in New Jersey. Whitman praised the Bush Administration's “strong belief that environmental protection and economic prosperity can and must go hand-in-hand.” She also specifically identified EPA's revised CAFO regulations among several key accomplishments of the agency during her tenure. According to Whitman, “[i]mprovements to the rules governing Concentrated Animal Feeding Operations will protect surface water by requiring reductions of at least 25 percent in runoff of nitrogen and phosphorous from those large agricultural operations.” Administrator Whitman's resignation letter is posted on EPA's website.

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights